Page 148we saw a powerful effect.” Blackburn, BTW, in 1985, co-discovered the
telomerase enzyme.
AMAS: A Revolutionary New Cancer Test
The cancer diagnostic test developed by Dr Samuel Bogach is called Anti-
Malignin Antibody in Serum or AMAS. It is a simple blood test for cancer which
is claimed to be 95% accurate on the first test and 99% accurate on repeat
analysis.
According to Oncolab, who administer the test, AMAS levels higher than 135
micrograms per milliliter (mcg/mL) are detected in patients with cancer 95% to
99% of the time. On the other hand, the AMAS level in the blood is below 135
mcg/mL if there is no cancer, or if cancer has been treated and cured.
In a 1990 abstract published in the Proceedings of the American Association
for Cancer Research, AMAS was used to evaluate patients with suspicious
mammograms. The average AMAS level in 154 control subjects (women who did
not have cancer) was 77 mcg/mL. Three of these patients had positive AMAS
levels 135 mcg/mL. and looked like false positives. However subsequently, one
was diagnosed as having in situ cancer of the cervix, another had basal cell
cancer of the skin and the third had ulcerative colitis (inflammation of the colon),
but did not have cancer.
In addition, twenty patients with biopsy-positive breast cancer had an average
AMAS level of 220 mcg/ml prior to surgery, which is very positive for cancer. In
fact many of the tumors removed were very small and could have been missed
by other diagnostic methods. In this study, the sensitivity of the AMAS test for
breast cancer was 95%.
The AMAS test was hailed as a breakthrough with the potential of saving millions
of human lives. “This test is destined to change the face of cancer care as we
know it,” says People Against Cancer’s executive director Frank D Wiewel.
Well, in the intervening years it hasn’t really happened yet. I think it’s fair to
say that it’s not as accurate or useful as claimed. But then all marker tests have
problems with sensitivity and specificity. One series I found suggested that false
positives and false negatives fell well below 10%, which is pretty good.
Even so, not all alternative cancer doctors support the validity of this test, or find
it helpful, but you should know about it. It is FDA approved.